Central Nervous System Diseases  >>  V-950  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
V-950 / Merck (MSD)
NCT00464334: A Study of V950 in People With Alzheimer Disease (V950-001 AM7)

Completed
1
86
US
V950, ISCOMATRIX™, Placebo to V950
Merck Sharp & Dohme LLC
Alzheimer Disease
01/12
01/12

Download Options